The New Face of US Science
Gary McDowell, Misty Heggeness and colleagues present census data showing how the biomedical workforce is fundamentally different to those of past generations – academia should study the trends, and adapt.
Send us a link
Gary McDowell, Misty Heggeness and colleagues present census data showing how the biomedical workforce is fundamentally different to those of past generations – academia should study the trends, and adapt.
Gingrich, the former House speaker and adviser to the president-elect, said "this is going to be a very science- and technology-oriented administration."
This January will not only mark a new year but a new administration and with that over 4000 new presidential appointees across the federal government. One appointment that has the potential to either hinder or benefit the biomedical research community is that of the director of the National Institutes of Health.
Trump’s timing on science jobs not unusual for presidents.
Eight highly-visible organizations today announced the launch of the Open Research Funders Group, a partnership designed to increase access to research outputs. With nearly $5 billion in combined annual grants conferred, these organizations are committed to using their positions to foster more open sharing of research articles and data. This openness, the members believe, will accelerate the pace of discovery, reduce information-sharing gaps, encourage innovation, and promote reproducibility.
A perspective by Kathy L. Hudson and Francis S. Collins on the 21st Century Cures Act.
Yesterday, President Obama signed the 21st Century Cures Act into law.
One Trump adviser suggested that NASA no longer should conduct climate research and instead should focus on space exploration.
As Silicon Valley fights for talent, universities struggle to hold on to their stars
NIH Director Dr. Francis Collins said Friday that it would be a "privilege" to remain in that post if asked to stay by President-elect Donald Trump.
Today, the Board on Higher Education and Workforce at the NAS announced the formation of a 16-person committee to work on the Next Generation of Researchers study. This study was commissioned by the U.S. Congress in the fiscal 2016 omnibus appropriations package that passed in December 2015.
Congress is poised to approve a massive piece of legislation that would provide the National Institutes of Health (NIH) with $4.8 billion over the next decade for a set of research initiatives, including brain and cancer research and efforts to develop so-called precision medicine treatments that are tailored to an individual’s genetic makeup.
The Association of American Universities worries that the open-access policies federal research agencies are developing now are not sufficiently aligned. Any slowdown in putting them in place, it says, is "probably a positive."
The winners in Trump's America were likely to be the defence industry, oil and energy, private prisons, and pharmaceutical manufacturers. Not health. What should be the response of the public health community?